HCWB (STOCKS)
HCW Biologics Inc. Common Stock
$0.825300
-0.164900 (-16.65%)
Prev close: $0.990200
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Hing C. Wong
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.72M
- Employees
- 36
- P/E (TTM)
- -0.06
- P/B (TTM)
- -1.03
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-2.02 | $-2.35 | +0.3260 | +13.90% |
|
Jun 2025 (Q2)
|
$-1.08 | $1.84 | -2.9160 | -158.82% |
|
Dec 2024 (Q4)
|
$-3.20 | $3.67 | -6.8720 | -187.15% |
|
Dec 2023 (Q4)
|
$-12.00 | $-5.71 | -6.2880 | -110.08% |
Financial Statements
| Revenues | $422.03K |
| Benefits Costs and Expenses | $32.59M |
| Cost Of Revenue | $337.62K |
| Costs And Expenses | $12.86M |
| Gross Profit | $84.41K |
| Operating Expenses | $11.96M |
| Research and Development | $5.16M |
| Other Operating Expenses | $6.80M |
| Operating Income/Loss | -$11.87M |
| Income/Loss From Continuing Operations After Tax | -$12.05M |
| Income/Loss From Continuing Operations Before Tax | -$32.17M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $848.84K |
| Net Income/Loss | -$12.05M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$12.05M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.21M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $10.15M |
| Preferred Stock Dividends And Other Adjustments | $10.15M |
| Basic Earnings Per Share | $15.68 |
| Diluted Earnings Per Share | $15.68 |
| Basic Average Shares | 41,561,002 |
| Diluted Average Shares | 41,561,002 |
| Assets | $25.45M |
| Current Assets | $1.59M |
| Accounts Receivable | $30.67K |
| Prepaid Expenses | $210.66K |
| Other Current Assets | $1.35M |
| Noncurrent Assets | $23.86M |
| Fixed Assets | $22.50M |
| Other Non-current Assets | $1.35M |
| Liabilities | $27.55M |
| Current Liabilities | $26.86M |
| Accounts Payable | $18.97M |
| Other Current Liabilities | $7.89M |
| Noncurrent Liabilities | $692.53K |
| Long-term Debt | $0.00 |
| Equity | -$2.11M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$2.11M |
| Liabilities And Equity | $25.45M |
| Net Cash Flow From Operating Activities | -$12.87M |
| Net Cash Flow From Operating Activities, Continuing | -$12.87M |
| Net Cash Flow From Investing Activities | $3.46M |
| Net Cash Flow From Investing Activities, Continuing | $3.46M |
| Net Cash Flow From Financing Activities | $13.08M |
| Net Cash Flow From Financing Activities, Continuing | $13.08M |
| Net Cash Flow | $3.68M |
| Net Cash Flow, Continuing | $3.68M |
| Comprehensive Income/Loss | -$12.05M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$12.05M |
| Other Comprehensive Income/Loss | $0.00 |